Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial
Titel:
Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial
Auteur:
McInnes, Iain B Behrens, Frank Mease, Philip J Kavanaugh, Arthur Ritchlin, Christopher Nash, Peter Masmitja, Jordi Gratacós Goupille, Philippe Korotaeva, Tatiana Gottlieb, Alice B Martin, Ruvie Ding, Kevin Pellet, Pascale Mpofu, Shephard Pricop, Luminita